High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
about
Apparent argatroban resistance in a patient with elevated factor VIII levels.Argatroban in heparin-induced thrombocytopenia: rationale for use and place in therapy.Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IILimitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban.Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trialDirect Thrombin Inhibitor Resistance and Possible Mechanisms.
P2860
High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High-dose argatroban for treat ...... of laboratory considerations.
@ast
High-dose argatroban for treat ...... of laboratory considerations.
@en
type
label
High-dose argatroban for treat ...... of laboratory considerations.
@ast
High-dose argatroban for treat ...... of laboratory considerations.
@en
prefLabel
High-dose argatroban for treat ...... of laboratory considerations.
@ast
High-dose argatroban for treat ...... of laboratory considerations.
@en
P2093
P356
P1476
High-dose argatroban for treat ...... of laboratory considerations.
@en
P2093
Gregory J Peitz
Michael P Gulseth
Thaddaus R Hellwig
P304
P356
10.2146/AJHP110147
P577
2012-03-01T00:00:00Z